Bordeaux, France

Florian Beaumatin

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Chu De Bordeaux, National Institute of Health and Medical Research. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Florian Beaumatin. Retrieved from https://idiyas.com/inventor/florian-beaumatin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Florian Beaumatin: Innovator in Biomarker Research

Introduction

Florian Beaumatin is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of biomarker research, particularly in relation to platelet age. His work has implications for various medical applications and enhances our understanding of platelet biology.

Latest Patents

Florian Beaumatin holds a patent titled "The Double Deamidated Form of BCL-XL is a Biomarker of Platelet Age." This patent represents a crucial advancement in identifying and understanding the aging process of platelets, which can have important clinical relevance.

Career Highlights

Throughout his career, Florian has worked with esteemed institutions such as Chu de Bordeaux and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to develop and refine his innovative ideas in the realm of biomarker research.

Collaborations

Florian has collaborated with talented individuals, including Muriel Priault and Chloé James. These partnerships have contributed to the success of his research and the development of his patent.

Conclusion

Florian Beaumatin is a distinguished inventor whose work in biomarker research has the potential to impact medical science significantly. His contributions, particularly through his patent, highlight the importance of innovation in understanding complex biological processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…